Targets for therapy in sarcomeric cardiomyopathies

To date, no compounds or interventions exist that treat or prevent sarcomeric cardiomyopathies. Established therapies currently improve the outcome, but novel therapies may be able to more fundamentally affect the disease process and course. Investigations of the pathomechanisms are generating molec...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cardiovasc Res
Glavni autori: Tardiff, Jil C., Carrier, Lucie, Bers, Donald M., Poggesi, Corrado, Ferrantini, Cecilia, Coppini, Raffaele, Maier, Lars S., Ashrafian, Houman, Huke, Sabine, van der Velden, Jolanda
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2015
Teme:
Invited Spotlight Reviews
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4402369/
https://ncbi.nlm.nih.gov/pubmed/25634554
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cvr/cvv023
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items